LYCALycia Therapeutics, Inc. insider trades
No insider bought or sold Lycia Therapeutics, Inc. (LYCA) shares on the open market in the last 90 days. The latest Form 4 transaction on record was filed on Oct 26.
- Market cap
- $1.50B
- as of 2026-10-26
- Latest close
- $28.85
- as of 2026-10-26
- Sector
- Healthcare
- as of 2026-10-26
- Industry
- Biotechnology
- as of 2026-10-26
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-10-26
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Laurent | Oct 22 | Oct 26 | A · derivative | 20,000 | $18.00 | $360,000 | 20,000 | No | Form 4 |
| Henderson Jane | Oct 22 | Oct 26 | A · derivative | 20,000 | $18.00 | $360,000 | 20,000 | No | Form 4 |
| Rieflin William Jl | Oct 22 | Oct 26 | A · derivative | 20,000 | $18.00 | $360,000 | 20,000 | No | Form 4 |
| Lee Chin HyokChief Medical Officer | Aug 11 | Oct 26 | A · derivative | 73,191 | $3.70 | $270,807 | 73,191 | No | Form 4 |
| Bachrodt AmyChief Financial Officer | Aug 11 | Oct 26 | A · derivative | 399,746 | $3.70 | $1,479,060 | 399,746 | No | Form 4 |
| Trombley Aetna WunPresident and CEO | Aug 11 | Oct 26 | A · derivative | 443,586 | $3.70 | $1,641,268 | 443,586 | No | Form 4 |
| Fischer Laurent | Aug 11 | Oct 26 | A · derivative | 13,307 | $3.70 | $49,236 | 13,307 | No | Form 4 |
| Henderson Jane | Aug 11 | Oct 26 | A · derivative | 57,666 | $3.70 | $213,364 | 57,666 | No | Form 4 |
| Rieflin William Jl | Aug 11 | Oct 26 | A · derivative | 24,840 | $3.70 | $91,908 | 24,840 | No | Form 4 |
| Touami SofiaChief Business Officer | Aug 11 | Oct 26 | A · derivative | 68,755 | $3.70 | $254,394 | 68,755 | No | Form 4 |
| Staben StevenChief Scientific Officer | Aug 11 | Oct 26 | A · derivative | 110,896 | $3.70 | $410,315 | 110,896 | No | Form 4 |